Glycemic control and critical illness: Is the kidney involved?

Journal of the American Society of Nephrology

Volumn 18, Issue 10, 2007, Pages 2623-2627

  Mehta, Ravindra L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRITICAL ILLNESS; GLOMERULUS FILTRATION RATE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HYPERGLYCEMIA; INSULIN METABOLISM; INSULIN RESISTANCE; KIDNEY; KIDNEY FUNCTION; KIDNEY INJURY; PRIORITY JOURNAL; REVIEW;

EID: 34948882675     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007010109     Document Type: Review

References (41)

1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367, 2001
2. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA: Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 80: 1558-1567, 2005
3. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449-461, 2006
4. Krinsley JS: Intensive glucose control in the ICU: An expert interview with James S. Krinsley, MD by Antonios Liolios. Med Gen Med 6: 33, 2004
5. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 290: 2041-2047, 2003
6. Bellomo R, Egi M: Glycemic control in the intensive care unit: Why we should wait for NICE-SUGAR. Mayo Clin Proc 80: 1546-1568, 2005
7. Turina M, Christ-Crain M, Polk HC Jr: Diabetes and hyperglycemia: Strict glycemic control. Crit Care Med 34[Suppl]: S291-S300, 2006
8. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114: 1187-1195, 2004
9. Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, Hoekstra JB: Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34: 96-101, 2006
10. Andreelli F, Jacquier D, Troy S: Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care 9: 124-130, 2006
11. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness? Curr Opin Crit Care 11: 304-311, 2005
12. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM: Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 66: 1613-1621, 2004
13. Basi S, Pupim LB, Simmons EM, Sezer MT, Shyr Y, Freedman S, Chertow GM, Mehta RL, Paganini E, Himmelfarb J, Ikizler TA: Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 289: F259-F264, 2005
14. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65: 1357-1365, 2004
15. Himmelfarb J, Le P, Klenzak J, Freedman S, McMenamin ME, Ikizler TA: Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney Int 66: 2354-2360, 2004
16. Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA, The PG: Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15: 2449-2456, 2004
17. Meyer C, Dostou JM, Gerich JE: Role of the human kidney in glucose counterregulation. Diabetes 48: 943-948, 1999
18. Asano T, Ogihara T, Katagiri H, Sakoda H, Ono H, Fujishiro M, Anai M, Kurihara H, Uchijima Y: Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs. Curr Med Chem 11: 2717-2724, 2004
19. Friedman JE, Dohm GL, Elton CW, Rovira A, Chen JJ, Leggett-Frazier N, Atkinson SM Jr, Thomas FT, Long SD, Caro JF: Muscle insulin resistance in uremic humans: Glucose transport, glucose transporters, and insulin receptors. Am J Physiol 261: E87-E94, 1991
20. Jacobs DB, Hayes GR, Truglia JA, Lockwood DH: Alterations of glucose transporter systems in insulin-resistant uremic rats. Am J Physiol 257: E193-E197, 1989
21. Portilla D, Li S, Nagothu KK, Megyesi J, Kaissling B, Schnackenberg L, Safirstein RL, Beger RD: Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int 69: 2194-2204, 2006
22. Schmidt C, Hocherl K, Bucher M: Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 292: F804-F811, 2007
23. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31: 359-366, 2003
24. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79: 992-1000, 2004
25. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R: Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 7: 7-11, 2006
26. Holm C, Horbrand F, Mayr M, von Donnersmarck GH, Muhlbauer W: Acute hyperglycaemia following thermal injury: Friend or foe? Resuscitation 60: 71-77, 2004
27. Cheung NW, Napier B, Zaccaria C, Fletcher JP: Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care 28: 2367-2371, 2005
28. Sarafidis PA, Ruilope LM: Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications. Am J Nephrol 26: 232-244, 2006
29. Feldkamp T, Kribben A, Roeser NF, Senter RA, Weinberg JM: Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation. Am J Physiol Renal Physiol 290: F465-F477, 2006
30. Zager RA, Johnson AC, Hanson SY: Renal tubular triglyceride accumulation following endotoxic, toxic, and ischemic injury. Kidney Int 67: 111-121, 2005
31. Weinberg JM: Lipotoxicity. Kidney Int 70: 1560-1566, 2006
32. Frankenfield DC, Reynolds HN: Nutritional effect of continuous hemodiafiltration. Nutrition 11: 388-393, 1995
33. Wooley JA, Btaiche IF, Good KL: Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 20: 176-191, 2005
34. Monson P, Mehta R: Nutritional considerations in continuous replacement therapy. Semin Dial 9: 152-160, 1996
35. Lonergan T, Compte AL, Willacy M, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Wong XW: A pilot study of the SPRINT protocol for tight glycemic control in critically ill patients. Diabetes Technol Ther 8: 449-462, 2006
36. Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ: Towards a feasible algorithm for tight glycaemic control in critically ill patients: A systematic review of the literature. Crit Care 10: R19, 2006
37. Lioubov S, Braithwaite S: Practical aspects of intensive insulinization in the intensive care unit. Curr Opin Clin Nutr Metab Care 10: 197-205, 2007
38. Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE: A simple insulin-nutrition protocol for tight glycemic control in critical illness: Development and protocol comparison. Diabetes Technol Ther 8: 191-206, 2006
39. Beste LA, Mersfelder TL: Hyperglycemia and gatifloxacin: A case report and summary of current literature. Am J Geriatr Pharmacother 3: 262-265, 2005
40. Mohr JF, McKinnon PS, Peymann PJ, Kenton I, Septimus E, Okhuysen PC: A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy 25: 1303-1309, 2005
41. Penfornis A, Kury-Paulin S: Immunosuppressive drug-induced diabetes. Diabetes Metab 32: 539-546, 2006